Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (18869)	4/8/1998 12:19:00 PM
From: WTDEC	Respond to of 32384

"I'm not sure who the "non-protocol" patients are, but it could be that they have not yet been treated long enough" Henry, since 'final' results were being reported for the PII trial, I assumed all patients would have completed all 12 weeks of the protocol, except if they dropped out for some reason. As you mentioned, the patients all had AIDS, so other complications probably caused many to fall outside of the protocol definition. Having more specific information on this would lift the 'cloud of uncertainty', so perhaps LGND will do so at the appropriate time. Regards, Walter